Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: A network meta-analysis

The Lancet

Volumn 387, Issue 10033, 2016, Pages 2093-2105

  Da Costa, Bruno R ^a   Reichenbach, Stephan ^a,b   Keller, Noah ^a   Nartey, Linda ^a   Wandel, Simon ^c   Jüni, Peter ^a,d,e   Trelle, Sven ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Wangen An der Aare   (Switzerland)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DICLOFENAC; ETORICOXIB; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; ROFECOXIB;

ARTICLE; COCHRANE LIBRARY; DOSE RESPONSE; DRUG EFFICACY; EMBASE; FOLLOW UP; HIP OSTEOARTHRITIS; HIP PAIN; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; AGED; ARTHRALGIA; BAYES THEOREM; COMPLICATION; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; BAYES THEOREM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84961221261     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30002-2     Document Type: Article

References (38)

1. R Altman, K Brandt, M Hochberg et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop Osteoarthritis Cartilage 4 1996 217 243
2. T Rosemann, M Wensing, K Joest, M Backenstrass, C Mahler, J Szecsenyi Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses BMC Musculoskelet Disord 7 2006 48
3. E Nuesch, P Dieppe, S Reichenbach, S Williams, S Iff, P Juni All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study BMJ 342 2011 d1165
4. M Porcheret, K Jordan, C Jinks, P Croft Primary care treatment of knee pain - a survey in older adults Rheumatology (Oxford) 46 2007 1694 1700
5. P Juni, S Reichenbach, P Dieppe Osteoarthritis: rational approach to treating the individual Best Pract Res Clin Rheumatol 20 2006 721 740
6. M Gore, KS Tai, A Sadosky, D Leslie, BR Stacey Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings Pain Pract 12 2012 550 560
7. M Gore, A Sadosky, D Leslie, KS Tai, M Seleznick Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis Clin Ther 33 2011 1914 1931
8. LR Arboleya, E de la Figuera, M Soledad Garcia, B Aragon Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs Curr Med Res Opin 19 2003 278 287
9. J Cordero-Ampuero, A Darder, J Santillana, MT Caloto, G Nocea Evaluation of patients' and physicians' expectations and attributes of osteoarthritis treatment using Kano methodology Qual Life Res 21 2012 1391 1404
10. TE McAlindon, RR Bannuru, MC Sullivan et al. OARSI guidelines for the non-surgical management of knee osteoarthritis Osteoarthritis Cartilage 22 2014 363 388
11. JM Bjordal, A Klovning, AE Ljunggren, L Slordal Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials Eur J Pain 11 2007 125 138
12. YF Chen, P Jobanputra, P Barton et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation Health Technol Assess 12 2008 1 278
13. R Chou, MS McDonagh, E Nakamoto, J Griffin Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review 2011 Agency for Healthcare Research and Quality (US) Rockville, MD
14. JP Higgins, A Whitehead Borrowing strength from external trials in a meta-analysis Stat Med 15 1996 2733 2749
15. S Trelle, S Reichenbach, S Wandel et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis BMJ 342 2011 c7086
16. E Nuesch, S Trelle, S Reichenbach et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study BMJ 341 2010 c3515
17. S Reichenbach, R Sterchi, M Scherer et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip Ann Intern Med 146 2007 580 590
18. G Higgins, S Green Cochrane handbook for systematic reviews of interventions version 5.1.0. Updated March, 2011 2011 The Cochrane Collaboration London
19. TC Smith, DJ Spiegelhalter, A Thomas Bayesian approaches to random-effects meta-analysis: a comparative study Stat Med 14 1995 2685 2699
20. G Lu, AE Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 2004 3105 3124
21. NJ Cooper, AJ Sutton, G Lu, K Khunti Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation Arch Intern Med 166 2006 1269 1275
22. J Cohen Statistical power analysis for the behavioral sciences 2nd edn. 1988 Lawrence Earlbaum Hillsdale
23. D Follmann, P Elliott, I Suh, J Cutler Variance imputation for overviews of clinical trials with continuous response J Clin Epidemiol 45 1992 769 773
24. DJ Spiegelhalter, KR Abrams, JP Myles Bayesian approaches to clinical trials and health care evaluation 2004 John Wiley & Sons Chichester
25. S Dias, NJ Welton, DM Caldwell, AE Ades Checking consistency in mixed treatment comparison meta-analysis Stat Med 29 2010 932 944
26. A Chaimani, JP Higgins, D Mavridis, P Spyridonos, G Salanti Graphical tools for network meta-analysis in STATA PLoS One 8 2013 e76654
27. S Wandel, P Juni, B Tendal et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis BMJ 341 2010 c4675
28. G Salanti, AE Ades, JP Ioannidis Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial J Clin Epidemiol 64 2011 163 171
29. A Adebajo Non-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care BMC Fam Pract 13 2012 23
30. N Bhala, J Emberson, A Merhi et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Lancet 382 2013 769 779
31. C Cahir, T Fahey, M Teeling, C Teljeur, J Feely, K Bennett Potentially inappropriate prescribing and cost outcomes for older people: a national population study Br J Clin Pharmacol 69 2010 543 552
32. Food and Drug Administration Guidance for industry providing clinical evidence of effectiveness for human drug and biological products 1998 Food and Drug Administration Rockville, MD
33. M Wadman NIH mulls rules for validating key results Nature 500 2013 14 16
34. AF Johnson Replication of multicenter clinical trials for efficacy? J Chronic Dis 38 1985 265 269
35. S Tacconelli, ML Capone, P Patrignani Clinical pharmacology of novel selective COX-2 inhibitors Curr Pharm Des 10 2004 589 601
36. GC Machado, CG Maher, PH Ferreira et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials BMJ 350 2015 h1225
37. RR Bannuru, CH Schmid, DM Kent, EE Vaysbrot, JB Wong, TE McAlindon Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis Ann Intern Med 162 2015 46 54
38. A van Walsem, S Pandhi, RM Nixon, P Guyot, A Karabis, RA Moore Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis Arthritis Res Ther 17 2015 66